ArticleMiddle East journal of digestive diseases2017

Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial.

Mohammad Reza Ghadir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.